Prevalence of type 2 diabetes association with rheumatoid arthritis among different obese and non-obese populations of Patna, India

Amrandra Prasad Singh

doi:10.18203/2320-6012.ijrms20190537

Authors

Amrandra Prasad Singh Department of Geriatrics, Patna Medical College and Hospital, Patna, Bihar, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20190537

Keywords:

Body Mass Index, Obesity, Rheumatoid arthritis, Type 2 diabetes

Abstract

Background: Type 2 Diabetes mellitus (T2DM) is the most common non-communicable chronic diseases in developed and developing countries around the world. The study reported the prevalence of diabetes association with rheumatoid arthritis (RA) among different obese and non-obese populations of Patna, India.

Methods: This clinic based descriptive study was conducted in Patna city from 1^st August 2017 to 30^th September 2018. A total 250 patients with diagnosed RA were enrolled. DM was defined according to the ADA recommendations as FBS ≥126mg/dl or oral glucose tolerance test OGTT2 ≥200mg/dl and HbA1c≥6.5. On the basis of the BMI calculated, patients were categorized either as obese or non-obese. Random diabetic detection was done to detect T2DM and followed by proper investigation at clinical laboratories. Patients also asked for hyperglycemic events during initial counselling.

Results: Mean BMI in obese was found to be 29.22±3.22 and in non-obese it was 22.99±1.38 (p<0.001). Most of the patients had been type 2 diabetes for more than 5 years duration. In both genders, an increasing trend was observed in the prevalence of type 2 diabetes with increasing BMI. Among these, a total of 198 (79.2%) were found to have diabetes, 115 (58.08%) of these were obese and 83 (41.91%) non-obese (p=0.003).

Conclusions: BMI is directly correlated to type 2 diabetes, as T2DM was significantly more common in obese patients with RA compared to non-obese patients with RA. Obese patients with RA had significantly more frequent diabetes.

Metrics

Metrics Loading ...

References

King RA, Rotter JI, Motulsky AG. The genetic basis of common diseases, 2nd ed. Oxford: Oxford-University; 1992.

Fraser FC. The William Allan memorial award address: evolution of a palatable multifactorial threshold model. Am J Human Gen. 1980;32(6):796.

Mueller RF, Young ID. Emery’s elements of medical genetics. London: Churchill Livingston; 1995.

Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368(9548):1681-8.

King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diab Care. 1993;16(1):157-77.

Pradhan R, Kumar BD, Mitra A. Some salient points in Type 2 diabetes prevalence in rural Bengal. Studies Ethno-Med. 2009;3(2):127-31.

Alberti KG, Zimmet PF. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diab Med. 1998;15(7):539-53.

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diab Res Clin Prac. 2010;87(1):4-14.

Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129-40.

Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diab Care. 1992;15(7):815-9.

Pirola L, Balcerczyk A, Okabe J, El-Osta A. Epigenetic phenomena linked to diabetic complications. Nature Rev Endocrinol. 2010;6(12):665.

Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheumatic Dis. 2012;71(9):1524-9.

Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheumatism. 1994;37(4):481-94.

Humphreys JH, Warner A, Chipping J, Marshall T, Lunt M, Symmons DP, et al. Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk Arthritis Register. Arthritis Care & Res. 2014;66(9):1296-301.

Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheumatic Dis. 2011;70(1):8-14.

Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatol. 2014;53(12):2143-54.

Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Therapy. 2009;11(3):229.

Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheumatic Dis. 2014;73(1):62-8.

Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Saccà L, et al. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diab. 2006;55(4):1133-40.

Albrecht K, Luque Ramos A, Hoffmann F, Redeker I, Zink A. High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data. Rheumatol. 2017;57(2):329-36.

D. H. Solomon, T. J. Love, C. Canning, and S. Schneeweiss. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheumatic Dis. 2010;69(12):2114-7.

Hanson L. Primary prevention of coronary heart disease: what is left to be done. Medicographia. 1998;20(3):183-6.

Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ. 2004;328(7443):807.